8.17, 2010
Finance & Alliance
Astellas Pharma Inc. and UMN Pharma Inc. Entered into a Memorandum of Understandings for UMN Pharma's Cell Culture Based Influenza Vaccine Program in Japan
2.21, 2007
Finance & Alliance
UMN Pharma completes $18.9 million Series C financing round, with participation of 20 investors.
8.29, 2006
Finance & Alliance
UMN Pharma signs a license agreement of UMN-05 with Protein Sciences Corporation.
2.03, 2006
Finance & Alliance
UMN Pharma completes $7.5 million Series B-2 financing round, with participation of 11 investors.
10.17, 2005
Finance & Alliance
UMN Pharma completes $1.1 million Series B-1 financing round, with participation of 3 venture capital firms.
7.22, 2005
Finance & Alliance
UMN Pharma completes $0.9 million Series A round (second tranche), with participation of 2 venture capital firms.
12.31, 2004
Finance & Alliance
UMN Pharma completes $0.9 million Series A round (first tranche), with participation of 2 venture capital firms.
